Human monoclonal antibody 98-6 reacts with the fusogenic form of gp41

Y Taniguchi1, S Zolla-Pazner, Y Xu

  • 1Laboratory of Virus Immunology, Kyoto University, Kyoto, 606-8507, Japan.

Virology
|August 1, 2000
PubMed

Insights

Human antibodies can recognize the fusogenic form of gp41, a key viral protein. A specific monoclonal antibody (mAb 98-6) targets a conformational epitope on gp41 oligomers and polyproteins in virions and infected cells.

Area of Science:

  • Virology
  • Immunology
  • Structural Biology

Background:

  • The gp41 protein of HIV-1 plays a critical role in viral fusion.
  • A specific alpha-helical structure formed by N36 and C34 peptides is believed to represent the fusogenic form of gp41.

Purpose of the Study:

  • To characterize the epitope recognized by a human anti-gp41 monoclonal antibody (mAb 98-6).
  • To determine the forms of gp41 and gp160 that present this epitope.

Main Methods:

  • Peptide binding assays with N36 and C34.
  • Immunoprecipitation of viral lysates and infected cell extracts.
  • Biotinylation of intact infected cells followed by lysis and immunoprecipitation.

Main Results:

  • mAb 98-6 binding to C34 was enhanced by N36, indicating recognition of a conformational epitope in the N36-C34 complex.
  • The epitope was detected on oligomeric forms of gp41 (dimers, trimers, tetramers) in virions.
  • The epitope was found on gp41 monomers, gp41 oligomers, and the gp160 polyprotein in infected cells.

Conclusions:

  • Infected individuals can mount an immune response against the fusogenic form of gp41.
  • mAb 98-6 recognizes a conformational epitope formed by the interaction of gp41 regions within an alpha-helical bundle.
  • This epitope is present on multiple forms of gp41 and gp160 in virions and infected cells.